Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas

Klaudyna Fidyt, Marta Krawczyk, Monika Pepek, Katsiaryna Marhelava, Agnieszka Kraft, Malgorzata Bobrowicz, Aleksandra Kusowska, Joanna Barankiewicz, Przemyslaw Juszczynski, Michal Smida, Myron Czuczman, Francisco Hernandez-Ilizaliturri, Malgorzata Firczuk, Magdalena Winiarska

Blood (2022) 140 (Supplement 1): 10273–10274.

https://doi.org/10.1182/blood-2022-162292

Published: 2022

Journal Articles

Optimized Method for Cell Surface Protein Identification on Primary B-Cell Precursor Acute Lymphoblastic Leukemia Cells

Katsiaryna Marhelava, Klaudyna Fidyt, Agata Malinowska, Bianka Swiderska, Monika Pepek, Agata Karolina Pastorczak, Agnieszka Kraft, Magdalena Winiarska, Malgorzata Firczuk

Blood (2022) 140 (Supplement 1): 11519–11520.

https://doi.org/10.1182/blood-2022-160084

Published: 2022

Journal Articles

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-134778

Published: 2020

Journal Articles

Innate-like Chemokine Receptor Profile and Migratory Behaviour By Terminally Differentiated and Educated NK Cells

Mieszko Lachota, Daniel Alfredo Palacios, MSc, Dennis Clement, MSc, Eivind Heggernes Ask, MD, Hanna Julie Hoel, MSc, Merete Thune Wiiger, PhD, Marianna Vincenti, MD, Magdalena Winiarska, Radoslaw Zagozdzon, MD PhD, Karl-Johan Malmberg, MD PhD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-140944

Published: 2020

Journal Articles

Pharmacological Induction of NOXA Sensitizes High-Risk B Cell Acute Lymphoblastic Leukemia Cells to Venetoclax

Klaudyna Fidyt, MSc, Julia Cyran, Agata Pastorczak, Nicholas T. Crump, Angelika Muchowicz, Agnieszka Goral, Krzysztof Domka, Lukasz Komorowski, Karolina Siudakowska, Agnieszka Graczyk-Jarzynka, Elzbieta Patkowska, Magdalena Winiarska, Jakub Golab, Thomas A. Milne, Malgorzata Firczuk, PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-139318

Published: 2020

Journal Articles

SHP1 Deficiency Is Responsible for the Constitutive Activation of the BCR Pathway in GCB DLBCL

Binu K Sasi, PhD, Sven Turkalj, BS, Hilal Kalkan, BS, Fabiola Porro, MS, Engin Bojnik, PhD, Beata Pyrzynska, PhD, Abdessamad Zerrouqi, PhD, Malgorzata Bobrowicz, PhD, Magdalena Winiarska, PhD, Valdemar Priebe, MS, Francesco Bertoni, MD, Larry Mansouri, PhD, Richard Rosenquist, MD PhD, Dimitar G Efremov, MD PhD

Blood (2018) 132 (Supplement 1): 2860.

https://doi.org/10.1182/blood-2018-99-118120

Published: 2018

Journal Articles

Dasatinib Effect on NK Cells and Anti-Tumor Immunity

Mieszko Lachota, Marta Siernicka, MSc, Zofia Pilch, PhD, Agnieszka Graczyk-Jarzynka, PhD, Magdalena Winiarska, PhD

Blood (2018) 132 (Supplement 1): 3004.

https://doi.org/10.1182/blood-2018-99-111280

Published: 2018

Journal Articles

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies

Blood (2017) 130 (14): 1628–1638.

https://doi.org/10.1182/blood-2016-08-736066

Published: 2017

Includes: Supplemental data

Journal Articles

HDAC6 Inhibition Increases Translation of CD20 mRNA and Potentiates the Efficacy of Anti-CD20 Immunotherapy

Malgorzata Bobrowicz, MSc, Joanna Stachura, MSc, Michal Dwojak, DMD, Antoni Domagala, MD, Beata Pyrzynska, PhD, Elise Berthel, MSc, Nicole Dalla Venezia, PhD, Marta Siernicka, MSc, Malgorzata Firczuk, PhD, Magdalena Winiarska, PhD

Blood (2016) 128 (22): 1586.

https://doi.org/10.1182/blood.V128.22.1586.1586

Published: 2016

Journal Articles

Lysosomal Disruption Augments Obinutuzumab-Induced Direct Cell Death

Antoni Domagala, MD, Malgorzata Bobrowicz, MSc, Joanna Stachura, MSc, Marta Siernicka, MSc, Piotr Mrowka, PhD, Michal Dwojak, DMD, Beata Pyrzynska, PhD, Malgorzata Firczuk, PhD, Magdalena Winiarska, PhD

Blood (2016) 128 (22): 2766.

https://doi.org/10.1182/blood.V128.22.2766.2766

Published: 2016

Journal Articles

HDAC Inhibitors As Potential New Agents Improving the Efficacy of Monoclonal Antibodies

Malgorzata Bobrowicz, MSc, Michal Dwojak, DMD, Agata Malenda, MD PhD, Kamil Bojarczuk, MSc, Marta Siernicka, MSc, Beata Pyrzynska, PhD, Ewa Lech-Maranda, MD PhD, Tomasz Stoklosa, MD PhD, Magdalena Winiarska, PhD, Jakub Golab, MD PhD

Blood (2014) 124 (21): 3641.

https://doi.org/10.1182/blood.V124.21.3641.3641

Published: 2014

Journal Articles

Influence of Btk Inhibitors on Antitumor Activity of Natural Killer Cells

Marta Siernicka, MSc, Kamil Bojarczuk, MSc, Malgorzata Bobrowicz, MSc, Michal Dwojak, DMD, Beata Pyrzynska, PhD, Daniel Olive, MD, PhD, Magdalena Winiarska, PhD

Blood (2014) 124 (21): 2742.

https://doi.org/10.1182/blood.V124.21.2742.2742

Published: 2014

Journal Articles

HDAC6 Inhibition Increases CD20 Level and Improves The Efficacy Of Anti-CD20 Monoclonal Antibodies

Malgorzata Bobrowicz, MSc, Michal Dwojak, Kamil Bojarczuk, MSc, Magdalena Winiarska, PhD, Jakub Golab, M.D., Ph.D.

Blood (2013) 122 (21): 4406.

https://doi.org/10.1182/blood.V122.21.4406.4406

Published: 2013

Journal Articles

Inhibitors Of B-Cell Receptor Molecules Affect Surface CD20 and Impair Antitumor Activity Of Anti-CD20 Monoclonal Antibodies

Kamil Bojarczuk, MSc, Magdalena Winiarska, PhD, Malgorzata Bobrowicz, MSc, Michal Dwojak, Nina Miazek, Piotr Zapala, Dimitar G Efremov, MD, PhD, Jakub Golab, M.D., Ph.D.

Blood (2013) 122 (21): 4217.

https://doi.org/10.1182/blood.V122.21.4217.4217

Published: 2013

Journal Articles

Inhibitors Of Src Family and AKT Regulate The Activity Of CD20 Promoter

Beata Pyrzynska, PhD, Kamil Bojarczuk, MSc, Magdalena Winiarska, PhD, Jacek Bil, MD, PhD, Nina Miazek, Piotr Zapala, Malgorzata Bobrowicz, MSc, Michal Dwojak, Marta Siernicka, Jakub Golab, M.D., Ph.D.

Blood (2013) 122 (21): 1838.

https://doi.org/10.1182/blood.V122.21.1838.1838

Published: 2013

Journal Articles

Src Family Tyrosine Kinases Are Involved in the Transcriptional Regulation of CD20 Levels

Magdalena Winiarska, PhD, Jacek Bil, MD, PhD, Kamil Bojarczuk, BSc, Dominika Nowis, MD, PhD, Malgorzata Wanczyk, MSc, Michal Dwojak, Grzegorz Basak, MD, PhD, Tomasz Stoklosa, MD, PhD, Jakub Golab, MD, PhD

Blood (2011) 118 (21): 1661.

https://doi.org/10.1182/blood.V118.21.1661.1661

Published: 2011

Journal Articles

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Eliza Glodkowska-Mrowka, MD, Piotr Mrowka, M.Sc., Magdalena Winiarska, PhD, Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Pawel Krzysztof Wlodarski, MD, PhD, Marek Jakobisiak, MD, PhD, Tomasz Stoklosa, MD, PhD

Blood (2011) 118 (21): 2742.

https://doi.org/10.1182/blood.V118.21.2742.2742

Published: 2011

Journal Articles

Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity,

Dominika Nowis, MD, PhD, Magdalena Winiarska, PhD, Jacek Bil, MD, PhD, Angelika Muchowicz, MSc, Malgorzata Wanczyk, MSc, Eliza Glodkowska-Mrowka, MD, Kamil Bojarczuk, BSc, Malgorzata Firczuk, PhD, Ewa Wilczek, PhD, Malgorzata Wachowska, MSc, Justyna Chlebowska, MSc, Michal Dwojak, Marta Miaczynska, PhD, Tomasz Stoklosa, MD, PhD, Jakub Golab, MD, PhD

Blood (2011) 118 (21): 3722.

https://doi.org/10.1182/blood.V118.21.3722.3722

Published: 2011

Journal Articles

Sorafenib Affects Membrane Complement Inhibitors and Improves Antitumor Activity of Rituximab,

Jakub Golab, MD, PhD, Jacek Bil, MD, PhD, Kamil Bojarczuk, BSc, Dominika Nowis, MD, PhD, Marcin Okroj, Ph.D., Grzegorz Basak, MD, PhD, Tomasz Stoklosa, MD, PhD, Magdalena Winiarska, PhD

Blood (2011) 118 (21): 3723.

https://doi.org/10.1182/blood.V118.21.3723.3723

Published: 2011

Journal Articles

Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity

Jacek Bil, Magdalena Winiarska, Dominika Nowis, Kamil Bojarczuk, Anna Dąbrowska-Iwanicka, Grzegorz W. Basak, Kazimierz Sułek, Marek Jakobisiak, Jakub Golab

Blood (2010) 115 (18): 3745–3755.

https://doi.org/10.1182/blood-2009-09-244129

Published: 2010

Includes: Supplemental data

NARROW

CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas

Optimized Method for Cell Surface Protein Identification on Primary B-Cell Precursor Acute Lymphoblastic Leukemia Cells

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Innate-like Chemokine Receptor Profile and Migratory Behaviour By Terminally Differentiated and Educated NK Cells

Pharmacological Induction of NOXA Sensitizes High-Risk B Cell Acute Lymphoblastic Leukemia Cells to Venetoclax

SHP1 Deficiency Is Responsible for the Constitutive Activation of the BCR Pathway in GCB DLBCL

Dasatinib Effect on NK Cells and Anti-Tumor Immunity

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies

HDAC6 Inhibition Increases Translation of CD20 mRNA and Potentiates the Efficacy of Anti-CD20 Immunotherapy

Lysosomal Disruption Augments Obinutuzumab-Induced Direct Cell Death

HDAC Inhibitors As Potential New Agents Improving the Efficacy of Monoclonal Antibodies

Influence of Btk Inhibitors on Antitumor Activity of Natural Killer Cells

HDAC6 Inhibition Increases CD20 Level and Improves The Efficacy Of Anti-CD20 Monoclonal Antibodies

Inhibitors Of B-Cell Receptor Molecules Affect Surface CD20 and Impair Antitumor Activity Of Anti-CD20 Monoclonal Antibodies

Inhibitors Of Src Family and AKT Regulate The Activity Of CD20 Promoter

Src Family Tyrosine Kinases Are Involved in the Transcriptional Regulation of CD20 Levels

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity,

Sorafenib Affects Membrane Complement Inhibitors and Improves Antitumor Activity of Rituximab,

Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only